Premier CEO: Have to get control over the pricing of drugs
Premier Inc. CEO Susan DeVore on efforts to rein in drug prices, innovation in health care, the resignation of FDA Chief Dr. Scott Gottlieb, the company's growth outlook and Amazon's joint health-care venture.